Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Beam Therapeutics
325 Vassar Street
Cambridge, MA 02139
Phone: 857-998-2547
https://beamtx.com/

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is backed by F-Prime Capital Partners and ARCH Venture Partners, two of the world's leading biotech venture capital firms.

Key Contact
Name
John Evans
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
05/14/18 $87,000,000 Series A ARCH Venture Partners
F-Prime Capital Partners
undisclosed
03/06/19 $135,000,000 Series B Altitude Life Science Ventures
ARCH Venture Partners
Cormorant Asset Management
Eight Roads
F-Prime Capital Partners
Omega Funds
Redmile Group
undisclosed


Featured Reading